Abstract:Objective To identify the clinical features, the molecular diagnosis and the molecular mechanism of three unrelated factor X deficiency families. Methods Three probands were male and the diagnosis was validated by coagulant parameters. The F X coagulation activity ( F X∶ C ) and antigen (FX∶ Ag) were tested by clotting test and ELISA method. The cross-corrected test was used to rule out the inhibitor of FX in plasma. Thrombin generation test was evaluated. The antigen and the molecule weight of the FX in plasma were measured with western blotting. Gene mutations were analyzed in the probands and their family members with PCR and DNA sequencing. FX expression plasmids were constructed and transientby being transfected into 293T cells. FX: C and FX: Ag of the expression products were tested. Results APTT and PT in proband 1 were obviously prolonged, 113.4 s and 62.3 s, respectively. And there was no inhibitor in plasma. The thrombin generation was lower compared to normal reference. APTT and PT in proband 2 were 56. 5 s and 28.7 s. There was no inhibitor in the plasma. The thrombin generation was 1 101.5 nmol · min. APTT and PT in proband 3 were 117.3 s and 44. 3 s. The thrombin generation was 782.5 nmol · min. FX∶ C and FX∶ Ag in proband 1 were 1.4% and 3.6%, with a homozygous mutation in FX gene (Ser425→Pro). In vitro expression of the mutation showed a normal synthesis in the cell but secretion dysfuntion. In proband 2 F X: C and F X: Ag were 2. 2% and 5. 5%, with two heterozygous mutations in FX gene (Ala-29→Pro and Phe324→Leu). The Ala-29 → Pro mutation led to significantly reduced expressions of FX in both cell lysate and cell culture supernatants compared to wild-type plasmid,(41.32 ±5.21 )% and(6. 30 ± 1.84)% respectively. However Phe324→Leu mutation almost did not affect the FX synthesis. FX: C and FX: Ag in proband 3 were 2. 2% and 35%, with two heterozygous mutations in FX gene( Ala235→Thr and Arg347→Cys). The expressions of these two mutant FX proteins in cell lysate were similar to those of wild-type but obviously lower in the supernatant. Conclusions Five mutations of F X gene are found in this study. These mutations (Ser425Pro, Phe324Leu, Ala235Thr and Arg347Cys)can not affect F X protein synthesis. However Ala-29Pro mutation can reduce F X protein synthesis and cause secretion dysfunction.

Prevalence, clinical characteristics and treatment outcome of factor X deficiency in a consecutive cohort of primary light-chain amyloidosis

Left Ventricular Myocardial Work Index and Short-Term Prognosis in Patients with Light-Chain Cardiac Amyloidosis: a Retrospective Cohort Study

Study on the molecular mechanism of the inherited factor X deficiency in three unrelated families

Association Between Health Status and Factor Consumption among Persons with Hemophilia B Using Propensity Score Matching

Clinical, Laboratory Aspects and Management of Factor X Deficiency

Clinical presentation and prognosis of light-chain amyloidosis patients with unmeasurable free light-chain levels

Bortezomib-based Treatment Can Improve Factor X Activity in Immunoglobulin Light-Chain Amyloidosis with Factor X Deficiency

Molecular Defects in the Factor X Gene Caused by Novel Heterozygous Mutations IVS5+1G>A and Asp409del.

Six novel missense mutations causing factor X deficiency and application of thrombin generation test.

A Compound Heterozygosis of Two Novel Mutations Causes Factor X Deficiency in a Chinese Pedigree

Posttreatment Dflc Less Than 10 Mg/l Predicts Superior Organ Response and Longer Time to Next Treatment in Newly Diagnosed Light-Chain Amyloidosis Patients Treated with Bortezomib

Factor X Shanghai And Disruption Of Translocation To The Endoplasmic Reticulum

Clinical manifestations and mutation spectrum of 57 subjects with congenital factor XI deficiency in China

A Single-Center Study of Patients with Isolated Acquired Clotting Factors Deficiency: Clinical Features, Treatments and Prognosis

Phenotype and genotype analysis of patients with severe factor XI deficiency in Shaanxi Province, China

Clinical characteristics and survival analysis of a large cohort of Light Chain amyloidosis: a single center real-world study

Identification of Genetic Defects Underlying FXII Deficiency in Four Unrelated Chinese Patients

A Novel Factor X Gene Mutation Val (GTC) 384ala (GCC) in a Chinese Family Resulting in Congenital Factor X Deficiency.

Global epidemiology of factor XI deficiency: A targeted review of the literature and foundation reports

Complete responses in AL amyloidosis are unequal - the impact of free light chain mass spectrometry in AL amyloidosis

Hereditary factor X deficiency in America survey: impact on quality of life and burden of disease in patients and caregivers